This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Health Care Notification Network
New Service Replaces Paper-based Product Safety Alerts With E-mails
"It's slow, it's expensive -- often with weeks of delay between the time a notice is required and (when) it actually reaches the physician's hands," Dickey said, referring to the current paper-based notification system. "It's ineffective -- literally stacks of mail come into a physician's office, and it's not uncommon for an alert to be mistaken for marketing and simply tossed away."
Indeed, in a 2006 guidance statement, the FDA specifically addressed the potential benefits of using electronic means to convey voluntary recall communications about FDA-regulated products and important drug safety information, acknowledging the potential pitfalls of using paper notices.
"Many are now concerned that these important drug information communications sent to physicians and other health care providers are not reaching the intended audience in a timely manner or at all," the FDA statement reads. "Letters to health care providers often are screened by one or more 'gatekeepers' and may not reach the intended recipients -- the providers who need the drug information for treating patients."
Mail-based System Heightens Liability Risk
The physician liability issue is key, according to Fotsch, and is the chief driver behind the widespread support the HCNN has achieved among medical liability carriers. To date, more than three dozen medical malpractice carriers have announced their support for the network.
Also signing on to the venture are some 20 health insurers and health care organizations, nearly a dozen medical societies and physician and trade organizations, and various other health care entities.
Janet Woodcock, M.D., acting director of the FDA's Center for Drug Evaluation and Research, saluted the HCNN "for stepping up to the plate and for providing this service."
"FDA fully supports the transition to an interactive, electronic information environment for safety information both for drugs and devices and for biologicals," Woodcock said during the launch event. "We feel this way, doctors and other prescribers, health care professionals, won't be hearing of problems first from the media or from concerned patients who come into their office. So they will not be blind-sided; they will have the emerging information as soon as it's available."
That same timeliness factor is prompting negotiations between the HCNN and the CDC regarding the possibility of using the network to send alerts about national public health emergencies, such as those pertaining to a major infectious disease outbreak or bioterrorism event.
Information Targeted by Specialty
Other benefits of the new service include the clinician's ability to add an office manager or other staff member to the list of designated recipients and a feature that makes it easy for clinicians to send patients appropriate information from HCNN alerts using the clinicians' pre-existing practice e-mail systems.
FDA Finds Yet More ED Agents Unsafe
'Blue Steel,' 'Hero' Join Long List of Hazardous 'Supplements' for Men
(4/2/2008)
Additional Resource
MedWatch: the FDA Safety Information and Adverse Event Reporting Program
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
AAFP, USPSTF Recommend Against Routine PSA Screening
Inadequate, Disordered Sleep Increases Diabetes Risk
Text Messaging Could Hike Vaccination Rates
Fluoroquinolones Tied to Greater Retinal Detachment Risk
Sanofi Announces DTaP Vaccine Shortage
AHRQ Resources Provide Ready Access to Research Data
Community-onset C. difficile Infections on the Rise
New FamilyDoctor.org Content Helps With Caring for Elderly
U.S. Measles Cases in 2011 Highest in 15 Years
FDA Warns of More Finasteride Side Effects
'Take-Back' Initiative Focuses on Destroying Unwanted Drugs
Bariatric Surgery May Help Combat Type 2 Diabetes
Certain Skin Products Tied to Mercury Poisoning
FDA Clarifies Citalopram Usage, Dosing Warnings
Veterans With PTSD at Heightened Risk for Opioid Abuse
ACP Releases Guideline on Type 2 Diabetes Management
Office Champions Seeking Applicants for Second Wave
Surgeon General Releases Report on Teen Smoking
USPSTF Issues Final Cervical Cancer Screening Recommendations
FDA Approves First Quadrivalent Influenza Vaccine
Survey: Physicians May Have Trouble Interpreting Cancer Statistics
AIM-HI Nutrition Questionnaire Can Open Dialogue
Statin, HIV/Hepatitis C Drug Interactions May Pose Risks
Statin Therapy Effective in Both Genders, Study Suggests
AAFP, CDC Announce Immunization Schedule Change
Family Physicians on Front Lines of Caring for Vets
ACIP Votes to Expand Tdap Recommendation
Recalled Oral Contraceptives Pose Pregnancy Risk
Studies Shed Light on Vaccine Side Effect Risks
Dosing Problems Prompt Recall of Infants' Tylenol Products
TB 'Superbug' Not Stateside Threat, Says FP
Adult Vaccination Coverage Remains Low, Says CDC
FDA Warns of Health Risk Tied to PPI Use
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
